Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/20/2009

er share.

Conference Call

Amylin will webcast its Quarterly Update Conference Call today at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. During the call, the Company plans to provide further details underlying its quarterly financial results, and information regarding assumptions for the remainder of 2009 operations.

The call will be webcast live through the "Investors" section of Amylin's corporate Web site at www.amylin.com. A slide presentation accompanying the conference call will also be available through the "Investors" section of Amylin's corporate Web site. To access the webcast and slide presentation, please log on to www.amylin.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (866) 730-5763 (U.S./Canada) or (857) 350-1587 (international), conference access code 44746855. A replay of the call will also be available by phone beginning approximately two hours after the close of the call and can be accessed at (888) 286-8010 (U.S./Canada) or (617) 801-6888 (international), conference access code 78094555.

Note Regarding Use of Non-GAAP Financial Measures

Amylin reports non-GAAP operating income (loss) excluding non-cash items and one-time items, which is a non-GAAP financial measure. The Company believes that investors' understanding of its progress towards its stated goal of generating sustainable positive non-GAAP operating results by the end of 2010 is enhanced by this disclosure. Amylin also reports non-GAAP research and development expenses net of cost-sharing payments, which is a non-GAAP financial measure. The Company believes that investors' understanding of Amylin's net investment in research and development activ
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... , April 28, 2015 /CNW/ - The group representing the ... drug tragedy left a two-hour meeting with Health Canada ... March 6th, Health Canada announced a $180 million support ... than six weeks after the Health Canada announcement and ... fully support the victims, the group representing ...
(Date:4/28/2015)... Israel , April 28, 2015 ... in its sixth funding cycle for U.S.- Israel ... and Energy Efficiency. To be considered, a project ... between a company and a university/research institution (one from the ... proposal should have significant commercial potential and the project outcome ...
(Date:4/27/2015)... Intarcia Therapeutics, Inc. today announced the closing of ... conversion option at a $5.5 billion Company valuation. Plans ... of additional head-to-head comparative and switch studies of ITCA ... therapies. In addition, proceeds from the financing will fund ... 650 in the United States , ...
Breaking Medicine Technology:Thalidomide Victims Gravely Concerned by Health Canada's Silence 2Opportunities for Funding U.S.-Israel Cooperation for Renewable Energy and Efficiency 2Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 2Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 3
... , , PITTSBURGH, Jan. 11 ... global, private High-Definition broadcasting network, has engineered a ... for world-renowned pharmaceutical and medical device companies. ... Novartis, Shire, Schering-Plough, Bristol-Myers Squib, Cardiovascular Research Foundation ...
... Maine, Jan. 11 IDEXX Laboratories, Inc. (Nasdaq: ... of 2,000 Catalyst Dx® chemistry analyzers in 2009, bringing ... in the first quarter of 2008, is a next ... integrated suite of analyzers and significantly expands the range ...
Cached Medicine Technology:VELOCITY Broadcasting Injects ROI into Pharmaceutical Sector by Engaging Medical Professionals with Experiential High-Definition Broadcast Events 2VELOCITY Broadcasting Injects ROI into Pharmaceutical Sector by Engaging Medical Professionals with Experiential High-Definition Broadcast Events 3IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers 2
(Date:4/28/2015)... 2015 Georgia State University’s School of ... that will partner with the school on efforts to ... nation that produces more tobacco and has more smokers ... China Tobacco Control Partnership-Tobacco Free Cities, will focus on ... to support tobacco control efforts and where public health ...
(Date:4/28/2015)... 2015 Tools4ever, the market leader ... today that they have been chosen by IT ... Identity and Access Management vendors. IT Central Station ... and Access Management tools by real users in ... analyzed their trends to come up with the ...
(Date:4/28/2015)... 28, 2015 A new survey from ... lung damage, 66 percent of Americans fear brain damage the ... Awareness Month in May, shed light on the need for ... help prevent a stroke. By controlling modifiable risk factors, ... stroke is a “ brain attack ” that occurs when ...
(Date:4/28/2015)... April 28, 2015 A first-in-human ... of Molecular Imaging and Biology showed initial safety, ... generation fluorine-18 labeled small-molecule PSMA inhibitor. The imaging ... in Baltimore, MD by study co-author, Martin G. ... evaluation of [18F]DCFPyL demonstrated a number of important ...
(Date:4/28/2015)... Colorado spine surgeon Donald Corenman, MD, ... popular spine education website NECKANDBACK.COM and his ... Media. This website has been redesigned to help patients ... spine, causes of neck and back pain, and conditions ... and personally answers questions in the neck and back ...
Breaking Medicine News(10 mins):Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:Tools4ever Chosen as Part of “Top Identity and Access Management Tools - 2015 Edition” 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 3Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3
... , ATLANTA, Nov. 30 Kool Smiles received ... one of InfoWorld ,s Top 100 IT ... Kool Smiles built a Wyse-based thin-client infrastructure to support the electronic ... States. With this roll-out now complete, Kool Smiles has implemented ...
... , , ... million people become infected with HIV, and two million die from ... Day 2009 the Global AIDS Alliance (GAA) calls on President Obama ... the World Health Organization (WHO) showing that the AIDS pandemic continues ...
... , SEATTLE, Nov. 30 Major League Baseball,s ... recently acquired by the Chicago White Sox, will receive the 2009 ... Baseball player who best exemplifies the honor, courage and dedication of ... , The 28-year-old Redlands, Calif., native made his MLB ...
... While recognizing significant impact, CBO analysis understates the ... The Blue Cross and Blue Shield Association (BCBSA) ... by the Congressional Budget Office (CBO): , The CBO ... experts have said for weeks: the Senate healthcare reform ...
... for lifelong residents of ,stroke belt, study finds ... in the "stroke belt" of the southern United States have ... even if they live elsewhere later, a new study shows. ... the North and South Carolina, Georgia, Tennessee, Arkansas, Mississippi and ...
... equivalent to 113 chest X-rays, study finds , MONDAY, Nov. ... have abdominal/pelvic CT scans receive additional unnecessary imaging tests that ... the study, 978 CT abdominal and pelvic series were performed ... of the patients were 30 to 50 years of age. ...
Cached Medicine News:Health News:Kool Smiles Named Among 2009 InfoWorld 100 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 3Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:Birth in South Raises Stroke Risk for Life 2Health News:Birth in South Raises Stroke Risk for Life 3Health News:CT Scan Patients May Get Unnecessary Imaging 2
... 233 is an assayed quality ... the measurements of total hemoglobin ... instrumentation. It is available in ... analyzer performance at varying points ...
... is an assayed quality control material for blood ... four (4) levels for monitoring analyzer performance at ... be used on multiple test analyzers (such as ... 600). QC623 is also for use on ITC ...
... an assayed quality control material used ... gas, electrolyte, metabolite, and CO-Oximeter instrumentation. ... makes it the ideal choice for ... available in three (3) levels for ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Medicine Products: